NO992562L - Anvendelse av blandinger av aktive bestanddeler, inneholdende phytostenoler og/eller phytostenol-estere og potensieringsmidler, for fremstilling av hypo-kolesterinemiske midler - Google Patents

Anvendelse av blandinger av aktive bestanddeler, inneholdende phytostenoler og/eller phytostenol-estere og potensieringsmidler, for fremstilling av hypo-kolesterinemiske midler

Info

Publication number
NO992562L
NO992562L NO992562A NO992562A NO992562L NO 992562 L NO992562 L NO 992562L NO 992562 A NO992562 A NO 992562A NO 992562 A NO992562 A NO 992562A NO 992562 L NO992562 L NO 992562L
Authority
NO
Norway
Prior art keywords
potentizers
phytostenols
preparation
active ingredient
ingredient mixtures
Prior art date
Application number
NO992562A
Other languages
English (en)
Norwegian (no)
Other versions
NO992562D0 (no
Inventor
Norbert Weitkemper
Bernd Fabry
Original Assignee
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26031678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992562(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19700796A external-priority patent/DE19700796C2/de
Application filed by Henkel Kgaa filed Critical Henkel Kgaa
Publication of NO992562D0 publication Critical patent/NO992562D0/no
Publication of NO992562L publication Critical patent/NO992562L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NO992562A 1996-11-28 1999-05-27 Anvendelse av blandinger av aktive bestanddeler, inneholdende phytostenoler og/eller phytostenol-estere og potensieringsmidler, for fremstilling av hypo-kolesterinemiske midler NO992562L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19649286 1996-11-28
DE19700796A DE19700796C2 (de) 1996-11-28 1997-01-13 Wirkstoffmischungen zur Verminderung des Cholesteringehaltes im Serum von Warmblütern
PCT/EP1997/006450 WO1998023277A1 (de) 1996-11-28 1997-11-19 Verwendung von wirkstoffmischungen, enthaltend phytostenole und/oder phytostenolester und potenzierungsmittel zur herstellung von hypocholesterinämischen mitteln

Publications (2)

Publication Number Publication Date
NO992562D0 NO992562D0 (no) 1999-05-27
NO992562L true NO992562L (no) 1999-05-27

Family

ID=26031678

Family Applications (2)

Application Number Title Priority Date Filing Date
NO992562A NO992562L (no) 1996-11-28 1999-05-27 Anvendelse av blandinger av aktive bestanddeler, inneholdende phytostenoler og/eller phytostenol-estere og potensieringsmidler, for fremstilling av hypo-kolesterinemiske midler
NO992564A NO992564L (no) 1996-11-28 1999-05-27 Anvendelsen av blandinger av aktive bestanddeler for fremstilling av hypokolesterinemiske midler

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO992564A NO992564L (no) 1996-11-28 1999-05-27 Anvendelsen av blandinger av aktive bestanddeler for fremstilling av hypokolesterinemiske midler

Country Status (10)

Country Link
US (1) US6383514B1 (es)
EP (2) EP0941097B1 (es)
JP (2) JP2001508046A (es)
AU (2) AU714993B2 (es)
CA (2) CA2273341A1 (es)
DK (2) DK0952837T3 (es)
ES (2) ES2182137T3 (es)
NO (2) NO992562L (es)
NZ (1) NZ335990A (es)
WO (2) WO1998023275A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0594612B2 (en) 1991-05-03 2010-02-24 Raisio Nutrition Ltd. Process for the preparation of a substance comprising a beta-sitostanol fatty acid ester or a mixture thereof
DE19750422C1 (de) * 1997-11-14 1998-11-26 Henkel Kgaa Verwendung von ausgewählten Phytostenolestern zur Herstellung von hypocholesterinämischen Mitteln
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
EP1064912B1 (de) * 1999-07-02 2004-01-28 Cognis Iberia, S.L. Mikrokapseln - I
US6677327B1 (en) 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
EP1600062A1 (en) * 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and sterols
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
US9637515B2 (en) * 2006-11-06 2017-05-02 Jina Pharmaceuticals, Inc. Guggulphospholipid methods and compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085939A (en) 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3203862A (en) 1960-03-11 1965-08-31 Jones John Harris Oral anti-hypercholesterol composition
US3089939A (en) 1960-04-06 1963-05-14 Kamborian Dip-type adhesive container
CA928140A (en) 1969-07-17 1973-06-12 A. Erickson Billy Clear cooking and salad oils having hypocholesterolemic properties
JPS57206336A (en) 1981-06-12 1982-12-17 Ajinomoto Co Inc Edible oil
CA1185500A (en) 1981-08-12 1985-04-16 Joseph Z. Zdrok Disposable respirator
EP0195311B2 (en) 1985-03-06 1996-01-17 Yoshikawa Oil & Fat Co., Ltd. Process for preparing fatty acid esters
JPS62186936A (ja) 1986-02-13 1987-08-15 Asahi Denka Kogyo Kk ステリン乳化乃至可溶化組成物
FR2620024B1 (fr) 1987-09-09 1991-03-15 Dermatologiques Et Composition cosmetique comportant un agent antiradicaux libres, et agent correspondant
US5362732A (en) * 1989-12-20 1994-11-08 University Of North Carolina At Chapel Hill Boronated compounds
EP0594612B2 (en) 1991-05-03 2010-02-24 Raisio Nutrition Ltd. Process for the preparation of a substance comprising a beta-sitostanol fatty acid ester or a mixture thereof
US5352458A (en) 1992-12-21 1994-10-04 Applied Genetics Inc. Tanning method using DNA repair liposomes
KR970008132B1 (ko) 1993-02-08 1997-05-21 전동원 생체 임상의학용 키틴 및 키토산 제조방법
US5470577A (en) 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
DE4323615A1 (de) 1993-07-12 1995-01-19 Schreiner Edelgard Mittel gegen vorzeitiges Altern der Haut
DE4442987C2 (de) 1994-12-02 1997-04-17 Henkel Kgaa Kationische Chitinabbauprodukte

Also Published As

Publication number Publication date
JP2001504505A (ja) 2001-04-03
AU714993B2 (en) 2000-01-13
NO992562D0 (no) 1999-05-27
EP0952837B1 (de) 2002-09-18
EP0952837A1 (de) 1999-11-03
AU5553198A (en) 1998-06-22
AU713665B2 (en) 1999-12-09
EP0941097A1 (de) 1999-09-15
US6383514B1 (en) 2002-05-07
NO992564D0 (no) 1999-05-27
JP2001508046A (ja) 2001-06-19
WO1998023277A1 (de) 1998-06-04
ES2182137T3 (es) 2003-03-01
DK0941097T3 (da) 2002-08-19
ES2176805T3 (es) 2002-12-01
NO992564L (no) 1999-05-27
EP0941097B1 (de) 2002-05-02
AU5322998A (en) 1998-06-22
DK0952837T3 (da) 2003-01-27
WO1998023275A1 (de) 1998-06-04
NZ335990A (en) 2000-10-27
CA2272754A1 (en) 1998-06-04
CA2273341A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
NO944526D0 (no) Medisinsk aerosolformulering
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
NO995137L (no) Fremstilling av höyaktive katalysatorer; katalysatorene og deres anvendelse
FI971776A7 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
HUP0100059A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
IL117962A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
BR9707501A (pt) Composto composição farmacêutica e uso do composto
DE69715482D1 (de) Herstellung von 1,1,1,3,3-Pentachlorbutan und von 1,1,1,3,3-Pentafluorbutan
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
DE69730723D1 (de) Medizinische aerosolformulierungen von formoterol
HUT77075A (hu) Hatóanyagok és alkalmazásuk
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
NO992562D0 (no) Anvendelse av blandinger av aktive bestanddeler, inneholdende phytostenoler og/eller phytostenol-estere og potensieringsmidler, for fremstilling av hypo-kolesterinemiske midler
DE69705628D1 (de) Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat
EP0960885A4 (en) DEPSIPEPTIDES AND MEDICATIONS, WHICH CONTAIN THE SAME AS ACTIVE INGREDIENCIES
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
EE03690B1 (et) Imidasopüridasiinid, neid sisaldav ravim ja nendekasutamine
HUP0104238A3 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
BR9509055A (pt) Imidazoloquinoxalinona uso da mesma e composiçao farmacêutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application